A mutation in the sodium channel is responsible for the association of long QT syndrome and familial atrial fibrillation

Tan, 1995, Electrophysiologic mechanisms of the long QT interval syndromes and torsade de pointes, Ann Intern Med, 122, 701, 10.7326/0003-4819-122-9-199505010-00009 Priori, 2003, Risk stratification in the long-QT syndrome, N Engl J Med, 348, 1866, 10.1056/NEJMoa022147 Tester, 2005, Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing, Heart Rhythm, 2, 505 Wang, 1995, SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome, Cell, 80, 805, 10.1016/0092-8674(95)90359-3 Chen, 2003, KCNQ1 gain-of-function mutation in familial atrial fibrillation, Science, 299, 251, 10.1126/science.1077771 Hong, 2005, De novo KCNQ1 mutation responsible for atrial fibrillation and short QT syndrome in utero, Cardiovas Res, 68, 433, 10.1016/j.cardiores.2005.06.023 Yang, 2004, Identification of a KCNE2 gain-of-function mutation in patients with familial atrial fibrillation, Am J Hum Genet, 75, 899, 10.1086/425342 Xia, 2005, A Kir2.1 gain-of-function mutation underlies familial atrial fibrillation, Biochem Biophys Res Commun, 332, 1012, 10.1016/j.bbrc.2005.05.054 Hong, 2005, Short QT syndrome and atrial fibrillation caused by mutation in KCNH2, J Cardiovasc Electrophysiol, 16, 394, 10.1046/j.1540-8167.2005.40621.x Olson, 2006, A Kv1.5 channelopathy due to KCNA5 loss-of-function mutation causes human atrial fibrillation, Hum Mol Genet, 15, 2185, 10.1093/hmg/ddl143 Eckardt, 2001, Brugada syndrome and supraventricular tachyarrhythmias: a novel association?, J Cardiovasc Electrophysiol, 12, 680, 10.1046/j.1540-8167.2001.00680.x Morita, 2002, Atrial fibrillation and atrial vulnerability in patients with Brugada syndrome, J Am Coll Cardiol, 40, 1437, 10.1016/S0735-1097(02)02167-8 Laitinen-Forsblom, 2006, SCN5A mutation associated with cardiac conduction defect and atrial arrhythmias, J Cardiovasc Electrophysiol, 17, 480, 10.1111/j.1540-8167.2006.00411.x Olson, 2005, Sodium channel mutations and susceptibility to heart failure and atrial fibrillation, JAMA, 293, 447, 10.1001/jama.293.4.447 Darbar, 2008, Cardiac sodium channel (SCN5A) variants associated with atrial fibrillation, Circulation, 117, 1927, 10.1161/CIRCULATIONAHA.107.757955 Ellinor, 2008, Cardiac sodium channel mutation in atrial fibrillation, Heart Rhythm, 5, 99, 10.1016/j.hrthm.2007.09.015 Antzelevitch, 2005, Brugada syndrome: report of the Second Consensus Conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association, Circulation, 111, 659, 10.1161/01.CIR.0000152479.54298.51 Darbar, 2008, Persistent atrial fibrillation is associated with reduced risk of torsades de pointes in patients with drug-induced long QT syndrome, J Am Coll Cardiol, 51, 836, 10.1016/j.jacc.2007.09.066 Schwartz, 1995, Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate: implications for gene-specific therapy, Circulation, 92, 3381, 10.1161/01.CIR.92.12.3381 Rivolta, 2001, Inherited Brugada and long QT-3 syndrome mutations of a single residue of the cardiac sodium channel confer distinct channel and clinical phenotypes, J Biol Chem, 276, 30623, 10.1074/jbc.M104471200 Chen, 1998, Genetic basis and molecular mechanism for idiopathic ventricular fibrillation, Nature, 392, 293, 10.1038/32675 Tan, 2001, A sodium-channel mutation causes isolated cardiac conduction disease, Nature, 409, 1043, 10.1038/35059090 Bezzina, 1999, A single Na+ channel mutation causing both long-QT and Brugada syndromes, Circ Res, 85, 1206, 10.1161/01.RES.85.12.1206 Kyndt, 2001, Novel SCN5A mutation leading either to isolated cardiac conduction defect or Brugada syndrome in a large French family, Circulation, 104, 3081, 10.1161/hc5001.100834 Vincent, 2003, Atrial arrhythmias in the inherited long QT syndrome: laboratory quirk or clinical arrhythmia?, J Cardiovasc Electrophysiol, 14, 1034, 10.1046/j.1540-8167.2003.03365.x Satoh, 1998, Cesium-induced atrial tachycardia degenerating into atrial fibrillation in dogs: atrial torsades de pointes?, J Cardiovasc Electrophysiol, 9, 970, 10.1111/j.1540-8167.1998.tb00137.x Kirchhof, 2003, Prolonged atrial action potential durations and polymorphic atrial tachyarrhythmias in patients with long QT syndrome, J Cardiovasc Electrophysiol, 14, 1027, 10.1046/j.1540-8167.2003.03165.x Vecchietti, 2007, In silico assessment of Y1795C and Y1795H SCN5A mutations: implication for inherited arrhythmogenic syndromes, Am J Physiol Heart Circ Physiol, 292, H56, 10.1152/ajpheart.00270.2006 Burashnikov, 2003, Reinduction of atrial fibrillation immediately after termination of the arrhythmia is mediated by late phase 3 early afterdepolarization-induced triggered activity, Circulation, 107, 2355, 10.1161/01.CIR.0000065578.00869.7C Hove-Madsen, 2004, Atrial fibrillation is associated with increased spontaneous calcium release from the sarcoplasmic reticulum in human atrial myocytes, Circulation, 110, 1358, 10.1161/01.CIR.0000141296.59876.87 Nagatomo, 2000, Preferential block of late sodium current in the LQT3 delta KPQ mutant by the class IC antiarrhythmic flecainide, Mol Pharmacol, 57, 101 Moss, 2005, Safety and efficacy of flecainide in subjects with long QT-3 syndrome (DeltaKPQ mutation): a randomized, double-blind, placebo-controlled clinical trial, Ann Noninvas Electrocardiol, 10, 59, 10.1111/j.1542-474X.2005.00077.x Benhorin, 2000, Effects of flecainide in patients with new SCN5A mutation: mutation-specific therapy for long-QT syndrome?, Circulation, 101, 1698, 10.1161/01.CIR.101.14.1698 An, 1998, Novel LQT-3 mutation affects Na channel activity through interactions between α- and β1 subunits, Circ Res, 83, 141, 10.1161/01.RES.83.2.141 Liu, 2002, Channel openings are necessary but not sufficient for use-dependent block of cardiac Na+ channels by flecainide: evidence from the analysis of disease-linked mutations, J Gen Physiol, 120, 39, 10.1085/jgp.20028558